Literature DB >> 25757030

Study on the distribution and elimination of the new hormone irisin in vivo: new discoveries regarding irisin.

J Lv1, Y Pan1, X Li2, D Cheng2, H Ju1, J Tian3, H Shi2, Y Zhang1.   

Abstract

Irisin is a newly discovered factor that is secreted by skeletal muscle and plays an important role in the homeostasis and metabolism of energy balance. This study used irisin radiolabeled with (125)I and small-animal SPECT/CT imaging to investigate the metabolic elimination and distribution of irisin in vivo. Irisin was labeled with (125)I using the Iodogen method. Small-animal SPECT/CT imaging was performed on C57/B16 mice at 15, 30, 60, 120, and 240 min after receiving a tail vein injection, and the radioactive distribution in the organs of mice was determined at 15, 60, and 120 min. Small-animal SPECT/CT imaging revealed the highest level of radioactivity in the gallbladder followed by the liver and kidney. Radioactivity decreased gradually with time in all organs. The radioactive distribution in the mice organs also showed that the highest %ID/g was in the gallbladder followed by the kidney and liver, and decreased gradually with time. The radioactivity in the gastric system reached its highest level at 60 min. Finally, our study showed the metabolic clearance of (125)I-irisin is achieved primarily through the hepatobiliary and renal system and provided the basis for the clinical application of irisin. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757030     DOI: 10.1055/s-0035-1547261

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

Review 1.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

Review 2.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

Review 3.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

Review 4.  Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Jie Hu; Yani Ke; Fangping Wu; Shan Liu; Conghua Ji; Xiaohong Zhu; Ying Zhang
Journal:  Gastroenterol Res Pract       Date:  2020-11-07       Impact factor: 2.260

Review 5.  Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence.

Authors:  Amanda Kornel; Danja J Den Hartogh; Panagiota Klentrou; Evangelia Tsiani
Journal:  Int J Mol Sci       Date:  2021-08-24       Impact factor: 6.208

Review 6.  The Emerging Role of Irisin in Cardiovascular Diseases.

Authors:  Jinjuan Fu; Fangtang Li; Yuanjuan Tang; Lin Cai; Chunyu Zeng; Yongjian Yang; Jian Yang
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

Review 7.  Current Evidence of the Role of the Myokine Irisin in Cancer.

Authors:  Evangelia Tsiani; Nicole Tsakiridis; Rozalia Kouvelioti; Alina Jaglanian; Panagiota Klentrou
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

8.  Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway.

Authors:  Xueying Tan; Guangjun Shi; Deguo Zhang; Ping Zhang; Luan Li; Nan Tang; Fei Huang; Xianguo Kong
Journal:  Onco Targets Ther       Date:  2019-09-04       Impact factor: 4.147

9.  Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study.

Authors:  Mingyuan Zhao; Xiaoshuang Zhou; Chengying Yuan; Rongshan Li; Yuehong Ma; Xiaoxian Tang
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.